Bristol Myers Squibb has secured FDA approval for its cancer drug, Opdivo, to fight microsatellite instability-high colorectal cancer this week after doubts about its ability to fight lung cancer. This form of colorectal cancer affects only 5% of colorectal sufferers,...
Myomo has announced that its wearable device, MyPro, has gained approval for launch in the European Union. The device functions as a lightweight brace with enables patients who have suffered a stroke or spinal cord injury to resume movement in weakened hands or arms...
Is Your Company Prepared for 2018? Navigating the New Revenue Recognition Standard Implementation In less than six months, the life science industry will be facing a financial crossroads. As the New Revenue Recognition Standard is implemented, companies will be...
Early today senators met to vote on a procedure dubbed “Vote-A-Rama” in which various parts of the House GOP bill, which passed house majority in May, before being sent first to the House and then to the President for approval. If approved, this bill would replace the...
Legislating Healthcare: Ensuring Patient Access in the Trump Administration Ensuring Patient Access in the Trump Administration During times of legislative changes, patients are often left to wonder how they and their care will be impacted. Advocacy experts must take...
